Melissa M. Vasbinder

1.7k total citations
23 papers, 823 citations indexed

About

Melissa M. Vasbinder is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Melissa M. Vasbinder has authored 23 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 11 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Melissa M. Vasbinder's work include Chemical Synthesis and Analysis (9 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). Melissa M. Vasbinder is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). Melissa M. Vasbinder collaborates with scholars based in United States, United Kingdom and Germany. Melissa M. Vasbinder's co-authors include Scott J. Miller, Jason E. Imbriglio, Elizabeth R. Jarvo, Carrie E. Aroyan, Michael P. Doyle, David C. Forbes, Ronald T. Raines, Cara L. Jenkins, Chad S. Peterson and Marina Protopopova and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Melissa M. Vasbinder

22 papers receiving 814 citations

Peers

Countries citing papers authored by Melissa M. Vasbinder

Since Specialization

Citations

This map shows the geographic impact of Melissa M. Vasbinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa M. Vasbinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa M. Vasbinder more than expected).

Fields of papers citing papers by Melissa M. Vasbinder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa M. Vasbinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa M. Vasbinder. The network helps show where Melissa M. Vasbinder may publish in the future.

Co-authorship network of co-authors of Melissa M. Vasbinder

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa M. Vasbinder. A scholar is included among the top collaborators of Melissa M. Vasbinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa M. Vasbinder. Melissa M. Vasbinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule 2021 ·ChemBioChem ·Tim J. Wigle, Yue Ren, Jennifer R. Molina, (unknown), Laurie B. Schenkel, Kerren K. Swinger, Kristy Kuplast‐Barr, Christina R. Majer, (unknown), Alvin Lu, (unknown), Ryan Abo, Anne E. Cheung, (unknown), Mario Niepel, Nicholas R. Perl, Melissa M. Vasbinder, Heike Keilhack, Kevin W. Kuntz	14
2	In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement 2020 ·Cell chemical biology ·Tim J. Wigle, (unknown), Laurie B. Schenkel, Yue Ren, (unknown), (unknown), Kerren K. Swinger, (unknown), Christina R. Majer, Alvin Lu, Mario Niepel, Nicholas R. Perl, Melissa M. Vasbinder, Heike Keilhack, Kevin W. Kuntz	17
3	Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes 2019 ·SLAS DISCOVERY ·Tim J. Wigle, (unknown), Christina R. Majer, Kerren K. Swinger, (unknown), Laurie B. Schenkel, Melissa M. Vasbinder, (unknown), (unknown), (unknown), Dennis Wegener, Paul Chang, Kevin W. Kuntz	17
4	Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors 2018 ·Journal of Medicinal Chemistry ·Bin Yang, Melissa M. Vasbinder, Alexander W. Hird, Qibin Su, Haixia Wang, Yan Yu, Dorin Toader, Paul D. Lyne, Jon Read, J. Breed, Stephanos Ioannidis, Chun Deng, Michael Grondine, (unknown), (unknown), Patrick Brassil, James W. Janetka	20
5	Abstract 1650: Discovery of AZD4573, a potent and selective inhibitor of CDK9 that enables transient target engagement for the treatment of hematologic malignancies 2018 ·Cancer Research ·Bernard Barlaam, Chris De Savi, Lisa Drew, Andrew D. Ferguson, Douglas Ferguson, Chungang Gu, (unknown), Alexander W. Hird, Michelle L. Lamb, Nichole O’Connell, Kurt G. Pike, Theresa A. Proia, Maryann San Martin, Melissa M. Vasbinder, (unknown), Jianyan Wang, Wenlin Shao	5
6	Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205 2017 ·Cancer Research ·Jason G. Kettle, Qibin Su, Neil P. Grimster, Sameer Kawatkar, Scott Throner, Richard Woessner, Huawei Chen, Geraldine Bebernitz, Kristen Bell, Erica Anderson, Linette Ruston, (unknown), Paul D. Lyne, Melissa M. Vasbinder, Claudio Chuaqui	5
7	Structure–Cytotoxicity Relationships of Analogues of N¹⁴-Desacetoxytubulysin H 2016 ·Journal of Medicinal Chemistry ·Dorin Toader, Fengjiang Wang, Lakshmaiah Gingipalli, Melissa M. Vasbinder, Mark J. Roth, Shenlan Mao, M. Block, Jay Harper, Thota Sambaiah, Mei Su, (unknown), Vahe Bedian, Adeela Kamal	12
8	Small molecule inhibitor of apoptosis proteins antagonists: a patent review 2015 ·Expert Opinion on Therapeutic Patents ·Alexander W. Hird, Brian Aquila, Edward J. Hennessy, Melissa M. Vasbinder, Bin Yang	16
9	Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity. 2013 ·Cancer Research ·Richard Woessner, Geraldine Bebernitz, Kirsten Bell, Robert Caccese, (unknown), Jason G. Kettle, (unknown), Patricia Schroeder, Qibin Su, Haixia Wang, Minwei Ye, Weijia Zheng, Michael Zinda, Paul D. Lyne, Melissa M. Vasbinder, Dennis Huszar, Claudio Chuaqui	0
10	Structure activity and structure property relationships of a novel series of potent inhibitors of Checkpoint kinases 2007 ·Lynsie Almeida, Susan Ashwell, (unknown), Patrick Brassil, (unknown), Chun Deng, Thomas W. Gero, (unknown), Candice L. Horn, Stephanos Ioannidis, James W. Janetka, Paul D. Lyne, Vibha Oza, Stephanie K. Springer, Mei Su, Dorin Toader, Melissa M. Vasbinder, Dingwei Yu, (unknown), Sonya Zabludoff	1
11	Amino acid-peptide-catalyzed enantioselective Morita–Baylis–Hillman reactions 2006 ·Tetrahedron ·Melissa M. Vasbinder, Jason E. Imbriglio, Scott J. Miller	44
12	Dual Catalyst Control in the Enantioselective Intramolecular Morita−Baylis−Hillman Reaction 2005 ·Organic Letters ·Carrie E. Aroyan, Melissa M. Vasbinder, Scott J. Miller	107
13	Peptide Bond Isosteres: Ester or (E)-Alkene in the Backbone of the Collagen Triple Helix 2005 ·Organic Letters ·Cara L. Jenkins, Melissa M. Vasbinder, Scott J. Miller, Ronald T. Raines	81
14	Dual Catalyst Control in the Amino Acid-Peptide-Catalyzed Enantioselective Baylis−Hillman Reaction 2003 ·Organic Letters ·Jason E. Imbriglio, Melissa M. Vasbinder, Scott J. Miller	141
15	Synthesis of the Pro-Gly Dipeptide Alkene Isostere Using Olefin Cross-Metathesis 2002 ·The Journal of Organic Chemistry ·Melissa M. Vasbinder, Scott J. Miller	19
16	Incorporation of Peptide Isosteres into Enantioselective Peptide-Based Catalysts as Mechanistic Probes This research is supported by the U.S. National Science Foundation (CHE-9874963). We are also grateful to the U.S. NIH (GM-57595), DuPont, Eli Lilly, Glaxo–Wellcome, and Merck for research support. S.J.M. is a Fellow of the Alfred P. Sloan Foundation, a Cottrell Scholar of Research Corporation, and a Camille Dreyfus Teacher-Scholar. 2001 ·Angewandte Chemie International Edition ·Melissa M. Vasbinder, Elizabeth R. Jarvo, Scott J. Miller	9
17	Incorporation of Peptide Isosteres into Enantioselective Peptide-Based Catalysts as Mechanistic Probes 2001 ·Angewandte Chemie International Edition ·Melissa M. Vasbinder, Elizabeth R. Jarvo, Scott J. Miller	90
18	Incorporation of Peptide Isosteres into Enantioselective Peptide-Based Catalysts as Mechanistic Probes 2001 ·Angewandte Chemie ·Melissa M. Vasbinder, Elizabeth R. Jarvo, Scott J. Miller	29
19	Asymmetric Acylation Reactions Catalyzed by Conformationally Biased Octapeptides 2000 ·Tetrahedron ·Elizabeth R. Jarvo, Melissa M. Vasbinder, Scott J. Miller	26
20	Enantiocontrol in the Generation and Diastereoselective Reactions of Catalytically Generated Oxonium and Iodonium Ylides. Metal-Stabilized Ylides as Reaction Intermediates 1998 ·Journal of the American Chemical Society ·Michael P. Doyle, David C. Forbes, Melissa M. Vasbinder, Chad S. Peterson	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact